Glaxosmithkline Pharmaceuticals has reported results for first quarter ended June 30, 2017.
The company has reported a fall of 63.44% in its net profit at Rs 26.42 crore for the quarter under review as compared to Rs 72.27 crore for the same quarter in the previous year. Total income of the company decreased by 14.89% at Rs 620.75 crore for Q1FY18 as compared Rs 729.35 crore for the corresponding quarter previous year.
GlaxoSmithKline Pharmaceuticals is a subsidiary of GlaxoSmithKline plc, one of the world's leading research-based pharmaceutical and healthcare companies, committed to improving the quality of human life by enabling people to do more, feel better and live longer.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |